Talk:Limb–girdle muscular dystrophy
Appearance
![]() | This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Limb–girdle muscular dystrophy.
|
This page has archives. Sections older than 90 days may be automatically archived by ClueBot III when more than 4 sections are present. |
![]() | This article contains broken links to one or more target anchors:
The anchors may have been removed, renamed, or are no longer valid. Please fix them by following the link above, checking the page history of the target pages, or updating the links. Remove this template after the problem is fixed | Report an error |
New research development about mevalonolactone should be mentioned on this page
[edit]See https://www.theatlantic.com/health/archive/2023/06/the-gene-that-explains-statins-most-puzzling-side-effect/674542/ about mevalonolactone as a successful treatment Quantum.presence (talk) 12:30, 29 June 2023 (UTC)
- see MEDRS [1],thank you--Ozzie10aaaa (talk) 13:25, 29 June 2023 (UTC)